New therapeutic agents in thrombosis and thrombolysis - 65 (3rd ed.)

As the number of patients with thrombosis and thrombolysis increases, there is a critical need for clinicians to learn the latest scientific discoveries and treatment options. This timely Third Editionis a comprehensive text for cardiologists, hematologists, and pharmacologists in need of a resource on current agent development technology for treating cardiovascular and thromboembolic diseases.

New to the Third Edition:

• a thorough examination of all the agents involved in treating thrombosis
• chapters on biomarkers, testing, and pharmacogenomics
• key topics, including new targets for antithrombotics, the development of novel classes of platelet inhibitors, new thrombolytic therapies, and evolving clinical uses of thrombolytics for ischemic stroke and venous thrombosis
• the hemostatic and thrombotic pathways